Literature DB >> 17261756

Epigenetics and the estrogen receptor.

Jennifer E Leader1, Chenguang Wang, Vladimir M Popov, Maofu Fu, Richard G Pestell.   

Abstract

The position effect variegation in Drosophila and Schizosaccharomyces pombe, and higher-order chromatin structure regulation in yeast, is orchestrated by modifier genes of the Su(var) group, (e.g., histone deacetylases ([HDACs]), protein phosphatases) and enhancer E(Var) group (e.g., ATP [adenosine 5'-triphosphate]-dependent nucleosome remodeling proteins). Higher-order chromatin structure is regulated in part by covalent modification of the N-terminal histone tails of chromatin, and histone tails in turn serve as platforms for recruitment of signaling modules that include nonhistone proteins such as heterochromatin protein (HP1) and NuRD. Because the enzymes governing chromatin structure through covalent modifications of histones (acetylation, methylation, phosphorylation, ubiquitination) can also target nonhistone substrates, a mechanism is in place by which epigenetic regulatory processes can affect the function of these alternate substrates. The posttranslational modification of histones, through phosphorylation and acetylation at specific residues, alters chromatin structure in an orchestrated manner in response to specific signals and is considered the basis of a "histone code." In an analogous manner, specific residues within transcription factors form a signaling module within the transcription factor to determine genetic target specificity and cellular fate. The architecture of these signaling cascades in transcription factors (SCITs) are poorly understood. The regulation of estrogen receptor (ERalpha) by enzymes that convey epigenetic signals is carefully orchestrated and is reviewed here.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17261756     DOI: 10.1196/annals.1386.047

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

1.  Histone deacetylase inhibitors suppress transdifferentiation of gonadotrophs to prolactin cells and proliferation of prolactin cells induced by diethylstilbestrol in male mouse pituitary.

Authors:  Nandar Tun; Yasuaki Shibata; Myat Thu Soe; Myo Win Htun; Takehiko Koji
Journal:  Histochem Cell Biol       Date:  2018-12-03       Impact factor: 4.304

Review 2.  Biosemiotics: a new understanding of life.

Authors:  Marcello Barbieri
Journal:  Naturwissenschaften       Date:  2008-03-26

3.  Histone deacetylation during brain development is essential for permanent masculinization of sexual behavior.

Authors:  Ken Ichi Matsuda; Hiroko Mori; Bridget M Nugent; Donald W Pfaff; Margaret M McCarthy; Mitsuhiro Kawata
Journal:  Endocrinology       Date:  2011-05-17       Impact factor: 4.736

Review 4.  The Epigenetics of Normal Pregnancy.

Authors:  Jonathan D Best; Nessa Carey
Journal:  Obstet Med       Date:  2013-03-01

5.  Molecular mechanisms underlying the fetal programming of adult disease.

Authors:  Thin Vo; Daniel B Hardy
Journal:  J Cell Commun Signal       Date:  2012-05-24       Impact factor: 5.782

Review 6.  What a difference an X or Y makes: sex chromosomes, gene dose, and epigenetics in sexual differentiation.

Authors:  Arthur P Arnold; Xuqi Chen; Yuichiro Itoh
Journal:  Handb Exp Pharmacol       Date:  2012

7.  Maternal protein restriction elevates cholesterol in adult rat offspring due to repressive changes in histone modifications at the cholesterol 7alpha-hydroxylase promoter.

Authors:  Gurjeev Sohi; Kelly Marchand; Andrew Revesz; Edith Arany; Daniel B Hardy
Journal:  Mol Endocrinol       Date:  2011-03-03

Review 8.  Epigenetics meets estrogen receptor: regulation of estrogen receptor by direct lysine methylation.

Authors:  Qun Zhou; Patrick G Shaw; Nancy E Davidson
Journal:  Endocr Relat Cancer       Date:  2009-02-10       Impact factor: 5.678

9.  Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance.

Authors:  Hugo H Ortega; Natalia R Salvetti; Vasantha Padmanabhan
Journal:  Reproduction       Date:  2009-03-04       Impact factor: 3.906

Review 10.  Tamoxifen resistance and epigenetic modifications in breast cancer cell lines.

Authors:  Eric Badia; Joan Oliva; Patrick Balaguer; Vincent Cavaillès
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.